About this trial
This study aims to fill the gaps regarding the effectiveness of paracetamol alone with paracetamol combined with cold sponging in febrile children.
Eligibility criteria
Qualifiers
Children of either gender
Aged 6 to 60 months.
Presenting with a fever (an axillary or oral temperature >38.0°C)
No use of paracetamol or other antipyretics within the past 6 hours. 4. Parental/guardian giving informed written consent.
Disqualifiers
Children with chronic systematic conditions (e.g., congenital heart defects, renal or respiratory diseases)
History of febrile seizures or other seizure disorders
Known hypersensitivity or contraindication to paracetamol
Presence of dermatological conditions that may aggravate by sponging (eg., eczema, contact dermatitis, psoriasis, skin infection, xerosis)
Trial design
Treatments tested in this trial
- Paracetamol
- Paracetamol+Cold Sponging
Treatment groups
Sponsors and collaborators
Muhammad Aamir Latif
Lead sponsor
RESnTEC, Institute of Research
Sponsor institution